Enzon Pharmaceuticals, Inc. (BST:EZ1)

Market Cap	5.08M
Revenue (ttm)	n/a
Net Income (ttm)	-2.22M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,140
Average Volume	3,261
Open	0.0565
Previous Close	0.0565
Day's Range	0.0565 - 0.0590
52-Week Range	0.0485 - 0.2300
Beta	n/a
RSI	48.51
Earnings Date	Nov 14, 2025

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: EZ1

Financial Performance

Financial numbers in USD